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Prediction model updating methods are aimed at improving the prediction performance of a
model in a new setting. This study sought to critically assess the impact of updating tech-
niques when applying existent prevalent diabetes prediction models to a population different
to the one in which they were developed, evaluating the performance in the mixed-ancestry
population of South Africa.
Methods
The study sample consisted of 1256 mixed-ancestry individuals from the Cape Town Bell-
ville-South cohort, of which 173 were excluded due to previously diagnosed diabetes and
162 individuals had undiagnosed diabetes. The primary outcome, undiagnosed diabetes,
was based on an oral glucose tolerance test. Model updating techniques and prediction
models were identified via recent systematic reviews. Model performance was assessed
using the C-statistic and expected/observed (E/O) events rates ratio.
Results
Intercept adjustment and logistic calibration improved calibration across all five models
(Cambridge, Kuwaiti, Omani, Rotterdam and Simplified Finnish diabetes risk models). This
was improved further by model revision, where likelihood ratio tests showed that the effect
of body mass index, waist circumference and family history of diabetes required additional
adjustment (Omani, Rotterdam and Finnish models). However, discrimination was poor fol-
lowing internal validation of these models. Re-estimation of the regression coefficients did
not increase performance, while the addition of new variables resulted in the highest dis-
criminatory and calibration performance combination for the models it was undertaken in.
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Conclusions
While the discriminatory performance of the original existent models during external valida-
tion were higher, calibration was poor. The highest performing models, based on discrimina-
tion and calibration, were the Omani diabetes model following model revision, and the
Cambridge diabetes risk model following the addition of waist circumference as a predictor.
However, while more extensive methods incorporating development population information
were superior over simpler methods, the increase in model performance was not great
enough for recommendation.
Introduction
Predictive performance is often decreased when a model is tested in a population different to
that in which the model was developed. To limit the number of models redeveloped in smaller
datasets due to poor performance of existent models, updating methods aim to improve the
prediction performance of a model in a new setting [1]. The updating of an existent model is
encouraged as it allows for the information captured during the development of the model to
be incorporated with the characteristics of the validation population [1–5].
Several updating methods are available in statistical literature [1, 4–6]. These methods vary
in the extent to which the model is adjusted, and range from simple recalibration, in which
only the intercept of the model may be updated, to more extensive updating, where all the
model parameters are re-estimated and new predictors are considered. There is no advocated
method to use, however there are limitations to both the most commonly used approach,
namely simple intercept correction, which does not account for the difference in strength of
the individual variables in the validation population, and the re-estimation of the regression
coefficients, which replaces unbiased estimates and fits the model with the validation outcome
prevalence, which can be unreliable [6]. Updating methods are, however, not a remedy against
poorly conceived and underpowered prediction research, nor do they guarantee complete
bridging of the gaps due to large differences between development and validation datasets.
How these methods alter the performance of existent prevalent diabetes risk prediction models
during the validation in empirical data has not yet been investigated.
In this study, we externally validate existent models, developed in different populations,
and applied the updating methods presented by Janssen et al [6], adapted from Steyerberg et al
[7], in a dataset from South Africa, where population specific diabetes risk prediction models
are not available. The performance was assessed to determine if they can be improved enough
to allow recommendation for use.
Materials and methods
Study population
Details of the study design and recruitment of the dataset that served as the basis for all updat-
ing methods implementation, are described in more detail elsewhere [8]. Briefly, Bellville-
South is located within the Northern suburbs of Cape Town, South Africa and is traditionally
a mixed-ancestry township formed in the late 1950s. The target population for this study were
subjects between the ages of 35 and 65 years of age and their number was estimated to be 6 500
in the 2001 population census [9]. The data was collected during January 2008 to March 2009,
and community authorities requested that participants outside the random selection area
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should benefit from the study. Recruited subjects gave written consent and were visited by the
recruitment team the evening before participation to be reminded of all the survey instruc-
tions. The study was approved by the Ethics Committee of the Cape Peninsula University of
Technology and Stellenbosch University.
Predictors
A questionnaire was administered to obtain information on lifestyle factors, such as smoking
and alcohol consumption, physical activity, diet, family history of diabetes mellitus, and demo-
graphics. A detailed drug history was obtained through interviews, the examination of the
clinic cards, as well as the recording of drugs that participants brought to the study site. Clini-
cal measurements included height, weight, hip and waist circumferences, body fat measure-
ments and blood pressure.
Outcome
All participants, except self-reported diabetic subjects, confirmed by either medical card
record or drugs in use, had blood taken for fasting blood glucose and underwent a 75 g oral
glucose tolerance test (OGTT), as prescribed by the World Health Organisation (WHO). Dia-
betes was diagnosed according to the WHO 2006 criteria [10].
Identification of prevalent diabetes prediction models
Existing prediction models were obtained from a systematic review by Brown et al, 2012 [11].
Models met the criteria for model selection for this paper if they were developed to predict the
presence of undiagnosed diabetes, and used only variables that were measured in the Bellville
South study. We focused on models developed from non-invasively measured predictors.
Therefore, the models retained were as follows: Cambridge Risk model [12], Kuwaiti Risk
model [13], Omani Diabetes Risk model [14], Rotterdam Predictive model 1 [15] and the sim-
plified Finnish Diabetes Risk model [16]. Model characteristics, formulas and development
performance are available elsewhere [17]. All models included age as a predictor, while a range
of other predictors were included in varying combinations in the models, namely sex, body
mass index (BMI), use of antihypertensive medication, family history of diabetes, waist cir-
cumference, past or current smoking and the use of corticosteroids.
Statistical methods
Analysis of missing data. The proportion of missing data for each predictor was deter-
mined, with family history having the most missing data [mother (25.1%), father (24.9%), sis-
ter (25.0%), and brother (25.1%)]. The remaining predictors had a missing proportion of less
than 5%, except smoking status (6.1%). During the comparison of several imputation methods
in this dataset on the effect on model performance, simple imputation (mean or mode substi-
tution) allowed for a similar predictive performance of a risk prediction model, when com-
pared to more complex imputation methods, and was therefore used to handle missing data in
this study, prior to the implementation of any updating methods [18].
Updating methods. Updating methods ranged in the extent to which both the original
model was altered and in the requirement of the development and validation datasets [6, 7,
19]. This study naturally did not have access to the development datasets of the selected preva-
lent diabetes risk prediction models, therefore excluding updating methods that required the
merging of both development and validation datasets. The selected models were initially run
without adjustment, Method 0, termed the ‘reference method’. These were run in the full
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dataset, as an external validation of these models, and to which all updating methods were
compared, to determine whether an updated formula could offer better validated predictive
performance. The updating techniques, explained by Janssen et al [6], were used to update the
prevalent diabetes risk prediction models in this study. The data was split, with two-thirds of
the data used for the implementation of the updating methods, and the final third used for
internal validation of the newly updated models. Methods 1 and 2 refer to recalibration.
Method 1 updated only the intercept using a correction factor to correct for the difference in
disease prevalence between the development and validation population, termed ‘intercept
adjustment.’ Method 2 updated both the intercept and the regression coefficients of the vari-
ables using the intercept and calibration slope from Method 1 respectively, termed ‘logistic
calibration.’ Method 3–5 were more comprehensive revision methods. Method 3, termed ‘revi-
sion,’ tested whether the effect of each variable is different in the updating dataset, following
the calibration of Method 2. Predictors were individually added as an offset, calculating a devi-
ation from the recalibrated regression coefficient based on Method 2. Likelihood ratio tests
were used to test whether this deviation has added predictive value. The same predictors and
regression coefficients from the original model were used, and the deviation of the predictors
with statistically significant differences was added to the linear predictor from Method 2.
Method 4, termed ‘re-estimation,’ was the complete re-estimation of the intercept and the
regression coefficients, fitting the predictors from the original models in the validation dataset.
Finally, the effect of additional predictors on each model was considered (Method 5). The fol-
lowing predictors were offered to each model univariately, following the same methodology as
Method 3 to test their statistical importance: Cambridge risk model: systolic blood pressure,
diastolic blood pressure, highest education status (categorical: primary school, high school,
university), use of lipid lowering drugs, drinking status (categorical: never, ex and current)
and waist circumference (�94cm for men,�80 for women); Kuwaiti risk model: sex, BMI
(categorical: 25 kg/m2� BMI < 30 kg/m2 and BMI� 30 kg/m2), systolic blood pressure,
diastolic blood pressure, education status, use of lipid lowering drugs, use of corticosteroids,
(categorical: never, ex and current) and drinking status; Omani diabetes risk model: sex, edu-
cation status, use of lipid lowering drugs, use of corticosteroids, smoking status and drinking
status; Rotterdam predictive model: systolic blood pressure, diastolic blood pressure, education
status, use of lipid lowering drugs, use of corticosteroids, family history of diabetes, smoking
status, drinking status and waist circumference; and simplified Finnish diabetes risk model:
sex, systolic blood pressure, diastolic blood pressure, education status, use of lipid lowering
drugs, use of corticosteroids, family history of diabetes, smoking status and drinking status.
Additional predictors were not offered to the models if they was already included in some
form. For methods 3–5, parameterwise model shrinkage was undertaken to adjust for possible
overfit. All analyses were conducted using the R software for statistical computing.
Model development. As a reference for the comparison of the model performance of the
model produced from each of the updating methods, a model was developed. Backward step-
wise selection was used to select the predictors. The predictors made available for selection
were sex, age, BMI (categorical: 25 kg/m2� BMI< 30 kg/m2 and BMI� 30 kg/m2), systolic
blood pressure, diastolic blood pressure, waist circumference (�94cm for men,�80 for
women), highest education status (categorical: primary school, high school, university), use of
hypertensive medication, use of lipid lowering drugs, use of corticosteroids, family history of
diabetes, smoking status (categorical: never, ex and current) and drinking status (categorical:
never, ex and current). A logistic regression model was fit with the selected predictors, with
coefficients shrunk parameterwise.
Model performance. The selected models were validated in the overall data using the
original structure, without any recalibration. The predicted probability of undiagnosed
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diabetes for each participant was computed using the baseline measured predictors. The per-
formance was expressed in terms of discrimination and calibration. Discrimination describes
the ability of the model’s performance in distinguishing those at a high risk of developing dia-
betes from those at low risk [20]. The discrimination was assessed and compared using con-
cordance (C) statistic [21].
Calibration describes the agreement between the probability of the outcome of interest as
estimated by the model, and the observed outcome frequencies [1]. It was assessed by calibra-
tion plots and computation of the expected (E) over observed (O) ratio (E/O); with the 95%
confidence intervals calculated assuming a Poisson distribution [22]. We also calculated 1) the
Yates slope, which is the difference between mean predicted probability of type 2 diabetes for
participants with and without prevalent undiagnosed diabetes, with higher values indicating
better performance; and 2) the Brier score, which is the squared difference between predicted
probability and actual outcome for each participant with values ranging between 0 for a perfect
prediction model and 1 for no match in prediction and outcome [1, 20].
Results
Updating dataset
The study sample consisted of 1256 individuals, of whom 173 were excluded due to previously
diagnosed diabetes. Of the final 1083 individuals, 329 (30.4%) had missing data, which were
imputed using simple imputation. The characteristic profile for the split datasets are described
in Table 1. The mean age was 51.9 (14.9) years and a total of 162 (15%) individuals had un-
diagnosed diabetes. The database included 832 (76.8%) females. A comparison between the
training and test datasets only showed a statistically significant difference for diastolic blood
pressure.
Table 1. Demographic characteristics of the Bellville South cohort, by the training and test datasets.
Variables Overall (1083) Training dataset Test dataset P-value
Prevalent undiagnosed diabetes (Yes, %) 162 (15.0) 118 (15.6) 44 (13.5) 0.354
Sex (Male, %) 251 (23.2) 169 (22.3) 82 (25.2) 0.174
Age (mean years, SD) 51.9 (14.9) 52.0 (14.9) 51.6 (15.1) 0.691
Body mass index (mean kg/m2, SD) 29.7 (7.0) 29.6 (6.9) 30.0 (7.4) 0.503
Waist circumference (mean cm, SD) 95.8 (15.3) 95.8 (15.2) 95.9 (15.6) 0.919
Systolic blood pressure (mean mmHg, SD) 124.3 (20.0) 123.6 (20.2) 126.1 (19.4) 0.056
Diastolic blood pressure (mean mmHg, SD) 76.0 (12.7) 75.4 (12.8) 77.3 (12.4) 0.026
Use of hypertensive medication (Yes, %) 374 (34.5) 268 (35.4) 106 (32.6) 0.142
Hypertensive status (Yes, %) 817 (75.4) 570 (75.2) 247 (76.0) 0.755
Use of lipid-lowering medication (Yes, %) 40 (3.7) 30 (4.0) 10 (3.1) 0.579
Use of corticosteroids (Yes, %) 12 (1.1) 5 (0.7) 7 (2.2) 0.062
Mother having diabetes (Yes, %) 124 (11.5) 87 (11.5) 37 (11.4) 0.999
Father having diabetes (Yes, %) 61 (5.6) 38 (5.0) 23 (7.1) 0.195
Sister having diabetes (Yes, %) 103 (9.5) 71 (9.4) 32 (9.9) 0.873
Brother having diabetes (Yes, %) 67 (6.2) 49 (6.5) 18 (5.5) 0.631
Alcohol use (Current, %) 272 (25.1) 186 (24.5) 86 (26.5) 0.384
Smoking status (Current, %) 433 (40.0) 304 (40.1) 129 (39.7) 0.847
Education (High School, %) 131 (12.1) 94 (12.4) 37 (11.4) 0.663
SD, standard deviation
https://doi.org/10.1371/journal.pone.0211528.t001
Performance of updated prevalent diabetes risk prediction models
PLOS ONE | https://doi.org/10.1371/journal.pone.0211528 February 7, 2019 5 / 12
Models parameters
Method 1–3 correction estimates are presented in Table 2, and full model formulas for the
original model, method 4 and method 5 are presented in Table 3, all derived in the training
dataset. Baseline predicted risks by the Cambridge and Omani diabetes risk models was too
low, requiring the intercept to be decreased further during the intercept adjustment (Method
1) (-6.322 to -7.205, and -4.700 to -5.083, respectively), while the predicted risk was too high
and the intercept increased for the Kuwaiti, Rotterdam and Simplified Finnish diabetes risk
models. Logistic calibration (Method 2) showed additional adjustment to the intercept of all
models, increasing the underlying risk, and the correction of the regression coefficients of the
original models with the calibration slopes from method 0, showed that all models required
the weighting of their predictors to be decreased. The likelihood ratio test results from model
revision showed no significantly different effect for any predictor for the Cambridge and
Kuwaiti risk models. A number of predictors required adjustment over and above the calibra-
tion slope adjustment from method 2 for the Omani diabetes risk model, namely a greater pre-
dictive effect of BMI� 30 kg/m2 (0.115) and a WC� 94 cm in men and� 80cm in women
(0.890) and a lower predictive effect for a parent or sibling having a history of diabetes
(-0.253). Only sex needed adjustment in the Rotterdam predictive model (-0.783), while age
(45 years� age� 54 years) and the use of hypertensive medication where reduced and
increased in the simplified Finnish diabetes risk model, respectively.
The re-estimation of the models (Method 4) yielded an intercept closer to 0 (when com-
pared to the original model) for all the models, with the exception of the Omani model (-4.700
to -4.716). When comparing the regression coefficients of the variables across the methods for
each model, there was variability, with direct comparisons largely difficult due to the differ-
ences in predictor categorisation. However, on the large, beta-coefficients were shrunk closer
to zero, with BMI and the use of hypertensive medication showing a larger predictive effect in
Table 2. Estimated parameters of the updating methods 1–3.
Method 1 Method 2 Method 3
Cambridge Diabetes Risk model Correction factor (1) / Calibration intercept (2–3) -0.883 - 1.617 -
Calibration slope used for linear predictor correction - 0.263 -
Kuwaiti Risk model Correction factor (1) / Calibration intercept (2–3) 0.304 -1.008 -
Calibration slope used for linear predictor correction - 0.342 -
Omani Diabetes Risk model Correction factor (1) / Calibration intercept (2–3) -0.383 -1.264 -0.837
Calibration slope used for linear predictor correction - 0.402 0.950
Deviation from recalibration regression coefficient: WC� 94cm in men and� 80cm in
women
- - 0.890
Parent or sibling history of diabetes - - -0.253
BMI� 30 kg/m2 - - 0.115
Rotterdam Predictive model Correction factor (1) / Calibration intercept (2–3) 0.593 -0.595 0.391
Calibration slope used for linear predictor correction - 0.541 1.134
Deviation from recalibration regression coefficient: Male gender - - -0.783
Simplified Finnish Diabetes Risk
model
Correction factor (1) / Calibration intercept (2–3) 1.212 -0.639 -0.256
Calibration slope used for linear predictor correction - 0.388 0.874
Deviation from recalibration regression coefficient: 45 years� age� 54 years - - -0.390
Prescribed antihypertensive medication - - 0.330
Method 1: correction factor updated intercept; Method 2: both the intercept and the regression coefficients of the variables using the intercept and calibration slope
from Method 1; Method 3: Extra adjustment of predictors with a different effect in the updating set compared to the derivation set, after recalibration by Method 2
https://doi.org/10.1371/journal.pone.0211528.t002
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Table 3. Intercept and regression coefficients of the updated models per existing model updated.
Method 0 Method 4 Method 5 Method 0 Method 4 Method 5
Cambridge Intercept -6.322 -3.419 -0.905 Rotterdam Intercept -3.020 -2.653 -1.435





1.222 0.587�� - model Male gender 0.460 0.184 -
Prescribed steroids 2.191 -0.657 - Use of antihypertensive
medication
0.420 0.664�� -
Age 0.063 0.030��� - BMI� 30 kg/m2 0.510 0.767��� -
25 kg/m2� BMI� 27.49 kg/m2 0.699 0.291 - Linear predictor - - 0.857
27.5 kg/m2� BMI� 29.99 kg/m2 1.970 0.002 - Parent and sibling has diabetes - - 1.136
BMI� 30 kg/m2 2.518 0.695��� - WC� 94cm (M) and� 80cm
(W)
- - 1.290
Parent or sibling has diabetes 0.728 -0.142 - Simplified Intercept -5.514 -4.080 -1.627
Parent and sibling has diabetes 0.753 0.989� - Finnish 45 years� age� 54 years 0.628 0.108 -
Ex-smoker -0.218 -11.312 - Diabetes 55 years� age� 64 years 0.892 0.692 -
Current smoker 0.855 -0.054 - Risk
model
25 kg/m2� BMI < 30 kg/m2 0.165 2.569 -
Linear predictor - - 0.865 BMI > 30 kg/m2 1.096 3.075 -
WC� 94cm (M) and� 80cm
(W)
- - 0.789 94cm�WC < 102cm in men
80cm�WC < 88cm in women
0.857 -0.337� -










0.978 0.755��� - History of high blood glucose† - - -
Age� 35 years 1.315 1.029� - Linear predictor - - 0.885
Waist circumference > 100 cm 1.930 0.992��� - SBP - - 0.011
Linear predictor - - 0.955 Parent and sibling has diabetes - - 0.956
SBP - - 0.009
Omani Intercept -4.700 -4.716 - Developed Intercept -5.136 - -
Diabetes 40 years� age� 59 years 1.800 0.941�� - model Age in years 0.028��� - -
Risk
model
Age� 60 years 2.300 1.544��� - Parent and sibling has diabetes 1.058�� - -
WC� 94cm (M) and� 80cm
(W)
0.380 0.088�� - WC� 94cm (M) and� 80cm
(W)
1.154�� - -
25 kg/m2� BMI < 30 kg/m2 0.540 1.880 - Use of antihypertensive
medication
0.516�� - -
BMI� 30 kg/m2 0.690 1.967 - SBP 0.004 - -
Parental or sibling history of
diabetes
1.900 0.447 - Use of lipid lowering medication -0.146 - -
SBP�140 and/or DBP�90 0.730 0.529 - BMI > 30 kg/m2 0.281 - -
Method 0: original risk model; Method 1: correction factor updated intercept; Method 2: both the intercept and the regression coefficients of the variables using the
intercept and calibration slope from Method 1; Method 3: Extra adjustment of predictors with a different effect in the updating set compared to the derivation set, after
recalibration by Method 2; Method 4: complete re-estimation of the intercept and the regression coefficients, fitting the variables from the original models in the





† assumed to be 0 for all participants due to the nature of this study.
https://doi.org/10.1371/journal.pone.0211528.t003
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the Omani, Rotterdam and Finnish risk models. Finally, the investigation into the effect of
additional predictors showed statistically significant selection in all but the Omani model. A
waist circumference of>94 cm in men and> 80 cm in women was added to both the Cam-
bridge and Rotterdam models, systolic blood pressure to both the Kuwaiti and Finnish models,
and a parent and sibling history of diabetes to both the Rotterdam and Finnish models. The
development of a model in this dataset, while not the aim of this study, included these three
predictors, as well as age, the use of hypertensive medication, the use of lipid lowering medica-
tion and a BMI > 30 kg/m2.
Model performance
Tables 4 and 5 show that the model performance across the methods in both the training and
test datasets. The original models, fit as they were developed in the full dataset, showed average
to moderate discrimination and poor calibration (shown in Fig 1, row 1). As expected, perfor-
mance across all methods was higher when developing the updated model, with small to large
drops in performance when validated. The intercept adjustment and logistic calibration had
little effect on the discriminative ability of the models in the training dataset (we expected, and
this would have no effect in the full dataset), with a drop in the C-statistic when internally vali-
dated. However, calibration was improved across all models, which was largely held after vali-
dation, although more pronounced in the Cambridge and Omani models [Method 2, E/O:
0.85 (0.63–1.14) and 0.86 (0.64–1.16), respectively], supported by the calibration curves (Fig 1,
row 3) showed a marked improvement closer to the ideal 45˚ line. Model revision improved
the discrimination when developed, however this was only an improvement on previous meth-
ods and external validation by the Rotterdam model [C-statistic, Method 1 and 2: 0.58 (0.49–
0.67), and Method 3: 0.62 (0.53–0.72)]. The adjustment of the coefficient of a number of
Table 4. Performance of the prevalent diabetes risk prediction models across updating methods 0–3.
Models Reference method Intercept adjustment (Method 1) Logistic calibration (Method 2) Revision (Method 3)
Train Test Train Test Train Test
Cambridge E/O (95% CI) 0.48 (0.41; 0.56) 0.79 (0.66; 0.95) 0.67 (0.50–0.90) 1.00 (0.84; 1.20) 0.85 (0.63–1.14) - -
Diabetes Brier score 0.181 0.139 0.147 0.122 0.118 - -
Risk Yates slope 0.174 0.153 0.100 0.079 0.049 - -
Model C-statistic (95% CI) 0.69 (0.65–0.73) 0.72 (0.67–0.76) 0.62 (0.53–0.71) 0.72 (0.67–0.76) 0.62 (0.53–0.71) - -
Kuwaiti Risk E/O (95% CI) 1.27 (1.09; 1.48) 1.05 (0.88; 1.26) 0.97 (0.72–1.30) 1.00 (0.84; 1.20) 0.91 (0.67–1.22) - -
model Brier score 0.122 0.123 0.123 0.120 0.117 - -
Yates slope 0.097 0.127 0.078 0.093 0.055 - -
C-statistic (95% CI) 0.70 (0.66–0.74) 0.73 (0.68–0.78) 0.62 (0.53–0.71) 0.73 (0.68–0.78) 0.62 (0.53–0.71) - -
Omani E/O (95% CI) 0.70 (0.60; 0.82) 0.93 (0.78; 1.12) 0.80 (0.59–1.07) 1.00 (0.84; 1.20) 0.86 (0.64–1.16) 1.00 (0.84; 1.20) 1.01 (0.75–1.36)
Diabetes Brier score 0.142 0.135 0.127 0.125 0.114 0.123 0.114
Risk model Yates slope 0.110 0.093 0.092 0.052 0.049 0.063 0.036
C-statistic (95% CI) 0.67 (0.63–0.71) 0.68 (0.63–0.73) 0.65 (0.57–0.73) 0.68 (0.63–0.73) 0.65 (0.57–0.73) 0.70 (0.66–0.70) 0.63 (0.55–0.72)
Rotterdam E/O (95% CI) 1.62 (1.38; 1.88) 1.01 (0.85; 1.22) 0.88 (0.65–1.18) 1.00 (0.84; 1.20) 0.86 (0.64–1.16) 1.00 (0.84; 1.20) 1.03 (0.76–1.38)
Predictive Brier score 0.126 0.125 0.118 0.125 0.119 0.122 0.114
model Yates slope 0.024 0.043 0.017 0.055 0.022 0.071 0.020
C-statistic (95% CI) 0.66 (0.61–0.70) 0.68 (0.63–0.74) 0.58 (0.49–0.67) 0.68 (0.63–0.74) 0.58 (0.49–0.67) 0.69 (0.64–0.75) 0.62 (0.53–0.72)
Simplified E/O (95% CI) 2.92 (2.51; 3.41) 1.09 (0.91; 1.31) 1.00 (0.74–1.34) 1.00 (0.84; 1.20) 0.90 (0.67–1.21) 1.00 (0.84; 1.20) 0.97 (0.72–1.31)
Finnish Brier score 0.133 0.128 0.119 0.125 0.116 0.124 0.115
Diabetes Yates slope 0.026 0.069 0.050 0.051 0.035 0.061 0.023
Risk model C-statistic (95% CI) 0.66 (0.62–0.70) 0.68 (0.64–0.73) 0.61 (0.52–0.70) 0.68 (0.64–0.73) 0.61 (0.52–0.70) 0.79 (0.66–0.75) 0.59 (0.50–0.68)
https://doi.org/10.1371/journal.pone.0211528.t004
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predictors in Method 3 did improve the calibration enough to show near perfect E/O ratio’s
after internal validation [Omani: 1.01 (0.75–1.36), Rotterdam: 1.03 (0.76–1.38), Finnish: 0.97
(0.72–1.31).
Interestingly, the re-estimation of the regression coefficients was not able to increase the
validated discrimination or calibration past that achieved by any of the other updating methods
for the Cambridge Omani, Rotterdam or Finnish diabetes risk models. The re-estimation of the
Kuwaiti model achieved the same results as the basic logistic calibration. Finally, the addition of
new predictors resulted in the highest discriminatory and calibration performance combination
for all models (not done for the Omani model), when compared to the previous updating meth-
ods. The Brier score was slightly reduced with each updating method across all models, but was
fairly stable throughout validation. However, the Yates slope was more greatly affected by the
updates, decreasing significantly with model validations. The model developed, using no infor-
mation from an existing model, achieved a developed C-statistic of 0.74 (0.70–0.79), and excel-
lent calibration [E/O: 1.00 (0.84–1.20)], however this performance decreased after validation
[C-statistic: 0.56 (0.45–0.66); E/O: 0.89 (0.67–1.20)]. This was in contrast to the higher discri-
minatory performance of the validated existent models in their original format, however the
developed model was better calibrated. Overall, while the original models achieved greater dis-
crimination, the highest performing models, based on both discrimination and calibration,
were those updated: the Omani diabetes model following model revision, and the Cambridge
diabetes risk model following the addition of waist circumference as a predictor.
Table 5. Performance of the prevalent diabetes risk prediction models across updating methods 4 and 5.
Models Re-estimation (Method 4) Addition of new variables (Method 5)
Train Test Train Test
Cambridge E/O (95% CI) 1.00 (0.84; 1.20) 0.89 (0.67–1.20) 1.00 (0.84; 1.20) 1.00 (0.75–1.35)
Diabetes Brier score 0.127 0.123 0.121 0.114
Risk Yates slope 0.070 0.030 0.081 0.029
Model C-statistic (95% CI) 0.66 (0.61–0.72) 0.56 (0.45–0.66) 0.72 (0.68–0.77) 0.63 (0.54–0.72)
Kuwaiti Risk E/O (95% CI) 1.00 (0.84; 1.20) 0.91 (0.67–1.22) 1.00 (0.84; 1.20) 0.98 (0.73–1.31)
model Brier score 0.119 0.116 0.118 0.114
Yates slope 0.090 0.054 0.098 0.031
C-statistic (95% CI) 0.73 (0.68–0.73) 0.62 (0.53–0.70) 0.74 (0.69–0.74) 0.61 (0.52–0.70)
Omani E/O (95% CI) 1.00 (0.84; 1.20) 0.88 (0.66–1.19) - -
Diabetes Brier score 0.126 0.119 - -
Risk model Yates slope 0.070 0.045 - -
C-statistic (95% CI) 0.69 (0.64–0.74) 0.61 (0.52–0.70) - -
Rotterdam E/O (95% CI) 1.00 (0.84; 1.20) 0.87 (0.65–1.17) 1.00 (0.84; 1.20) 0.99 (0.74–1.33)
Predictive Brier score 0.122 0.118 0.120 0.115
model Yates slope 0.067 0.033 0.087 0.034
C-statistic (95% CI) 0.70 (0.65–0.70) 0.60 (0.51–0.69) 0.73 (0.68–0.78) 0.62 (0.53–0.72)
Simplified E/O (95% CI) 1.00 (0.84; 1.20) 0.88 (0.66–1.18) 1.00 (0.84; 1.20) 0.95 (0.71–1.28)
Finnish Brier score 0.132 0.125 0.122 0.114
Diabetes Yates slope 0.058 0.036 0.071 0.033
Risk model C-statistic (95% CI) 0.64 (0.59–0.69) 0.57 (0.48–0.67) 0.71 (0.66–0.76) 0.63 (0.54–0.72)
Developed E/O (95% CI) 1.00 (0.84; 1.20) 0.89 (0.67; 1.20)
Model Brier score 0.118 0.123
Yates slope 0.094 0.031
C-statistic (95% CI) 0.74 (0.70–0.79) 0.56 (0.45–0.66)
https://doi.org/10.1371/journal.pone.0211528.t005
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Discussion
The aim of this study was to compare the effects of different updating techniques on the per-
formance of existent diabetes risk prediction models. The performance of the existent models
in their original format was not considered sufficient to recommend implementation and the
updating methods were intended to aid in bettering the fit of these models. While discrimina-
tion was increased when implementing the updating methods, this was lost during internal
validation. However, calibration was greatly improved and held following validation. To deter-
mine the maximum predictive ability of this population using the available predictors, model
development was undertaken, to be used as a comparative. The performance in the develop-
ment dataset was good, with a number of updating methods matching this performance in
development, however overfitting resulted in a 0.18 drop in the c-statistic when internally
validated.
The over or under estimated prediction of risk models in new settings may often be due to
predictors or characteristics that are not incorporated into the model but do have an effect on
the final model parameters. With large disparities between the development and updating pop-
ulations, as in this study, simple recalibration methods (Methods 1 and 2) are not anticipated
to be able to fully adjust for the differences between the development and validation popula-
tions. The total re-estimation in the updating dataset (Method 4) is often undertaken in this
situation, however revision methods with more simple adjustments (Method 3) may also
achieve an increase in performance with the incorporation of this new information in the
model. The better performance of the updated Omani (Method 3) and Cambridge (Method 5)
diabetes risk prediction models, when compared to the developed model, indicate that the
Fig 1. Calibration curves for the risk prediction models across the updating methods.
https://doi.org/10.1371/journal.pone.0211528.g001
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information gained from previously developed models is important to retain. This can be cor-
roborated by the poorer performance of Method 4, where total re-estimation loses the develop-
ment population information, gained back in Method 5 when the original model is still
incorporated.
While higher discrimination and calibration would have been beneficial, it must be noted
that this dataset is relatively small, with fewer males, which may have played a role in the per-
formance of the models. This is the first study investigating the performance of prevalent dia-
betes risk prediction models with updating methods in Africa, and there are a large number of
variables collected in the Bellville South cohort database, allowing for five existent diabetes risk
prediction models to be validated and updated simultaneously Although unlikely, there may
be characteristics of the population which better predict prevalent diabetes, which were not
collected.
Model validation and updating is unquestionably advocated to prevent adding models to
the already saturated literature. The incorporation of information from a, generally larger and
statistically more powerful, development population is important in achieving optimum
model prediction. The increase in the external validation of existent models, with attempts to
better fit them to a different setting, will allow for the identification of models that are of lim-
ited value and the implementation of genuinely useful models, aiding diabetes screening in
developing countries where large powerful studies for model development are not as readily
available. And while there may be situations where the largely diverse population setting may
make existent models possibly too different for even the most complex of updating methods,
there is certainly still use for them [5, 6, 23].
In conclusion, comparison of the updating methods employed showed that the more exten-
sive methods incorporating development population information were superior over simpler
intercept adjustment or logistic calibration. While updating methods on models validated in
empirical data were able to improve calibration, they did not achieve the discrimination of the
models in their original format during externally validated. However, the best discrimination
and calibration combination was achieved from model updating, over external validation and
model development. Unfortunately, the increase in model performance, despite updating
methods, was not great enough to recommend further investigation or implementation
recommendation.
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